{
    "Rank": 607,
    "Study": {
        "ProtocolSection": {
            "IdentificationModule": {
                "NCTId": "NCT01366248",
                "OrgStudyIdInfo": {
                    "OrgStudyId": "09E-1237-01"
                },
                "SecondaryIdInfoList": {
                    "SecondaryIdInfo": [
                        {
                            "SecondaryId": "1R01AT005873",
                            "SecondaryIdType": "U.S. NIH Grant/Contract",
                            "SecondaryIdLink": "https://reporter.nih.gov/quickSearch/1R01AT005873"
                        }
                    ]
                },
                "Organization": {
                    "OrgFullName": "Bastyr University",
                    "OrgClass": "OTHER"
                },
                "BriefTitle": "Integrative Oncology Outcomes Study in Breast Cancer",
                "OfficialTitle": "Breast Cancer Integrative Oncology: Prospective Matched Controlled Outcomes Study",
                "Acronym": "IO-OS-BC"
            },
            "StatusModule": {
                "StatusVerifiedDate": "March 2018",
                "OverallStatus": "Completed",
                "ExpandedAccessInfo": {
                    "HasExpandedAccess": "No"
                },
                "StartDateStruct": {
                    "StartDate": "August 2010"
                },
                "PrimaryCompletionDateStruct": {
                    "PrimaryCompletionDate": "December 31, 2017",
                    "PrimaryCompletionDateType": "Actual"
                },
                "CompletionDateStruct": {
                    "CompletionDate": "December 31, 2017",
                    "CompletionDateType": "Actual"
                },
                "StudyFirstSubmitDate": "May 31, 2011",
                "StudyFirstSubmitQCDate": "June 2, 2011",
                "StudyFirstPostDateStruct": {
                    "StudyFirstPostDate": "June 6, 2011",
                    "StudyFirstPostDateType": "Estimate"
                },
                "LastUpdateSubmitDate": "March 21, 2018",
                "LastUpdatePostDateStruct": {
                    "LastUpdatePostDate": "March 22, 2018",
                    "LastUpdatePostDateType": "Actual"
                }
            },
            "SponsorCollaboratorsModule": {
                "ResponsibleParty": {
                    "ResponsiblePartyType": "Sponsor"
                },
                "LeadSponsor": {
                    "LeadSponsorName": "Bastyr University",
                    "LeadSponsorClass": "OTHER"
                },
                "CollaboratorList": {
                    "Collaborator": [
                        {
                            "CollaboratorName": "Fred Hutchinson Cancer Center",
                            "CollaboratorClass": "OTHER"
                        },
                        {
                            "CollaboratorName": "National Institutes of Health (NIH)",
                            "CollaboratorClass": "NIH"
                        },
                        {
                            "CollaboratorName": "National Center for Complementary and Integrative Health (NCCIH)",
                            "CollaboratorClass": "NIH"
                        },
                        {
                            "CollaboratorName": "Lotte & John Hecht Memorial Foundation",
                            "CollaboratorClass": "OTHER"
                        }
                    ]
                }
            },
            "OversightModule": {
                "OversightHasDMC": "Yes"
            },
            "DescriptionModule": {
                "BriefSummary": "This NIH-NCCAM funded epidemiologic research is being conducted as an observational prospective case-control study of the use of Complementary and Alternative Medicine (CAM) and Integrated Oncology (IO) and their effects on breast cancer patients in community settings.\n\nHypothesis: IO services improve patients' quality of life and decrease cancer recurrence rates in breast cancer patients as compared to women with similar disease states and prognoses who do not receive IO care, and may or may not use CAM treatment on their own."
            },
            "ConditionsModule": {
                "ConditionList": {
                    "Condition": [
                        "Breast Cancer"
                    ]
                }
            },
            "DesignModule": {
                "StudyType": "Observational",
                "DesignInfo": {
                    "DesignObservationalModelList": {
                        "DesignObservationalModel": [
                            "Case-Control"
                        ]
                    },
                    "DesignTimePerspectiveList": {
                        "DesignTimePerspective": [
                            "Prospective"
                        ]
                    }
                },
                "EnrollmentInfo": {
                    "EnrollmentCount": "750",
                    "EnrollmentType": "Actual"
                }
            },
            "ArmsInterventionsModule": {
                "ArmGroupList": {
                    "ArmGroup": [
                        {
                            "ArmGroupLabel": "IO Clinic Breast Cancer Patients",
                            "ArmGroupDescription": "Includes patients who are receiving care for their breast cancer at participating Seattle area IO clinics."
                        },
                        {
                            "ArmGroupLabel": "CSS Match-Control Patients",
                            "ArmGroupDescription": "For each IO clinic patient, an average of two (up to four) matched comparison cases will be recruited from the Washington State Cancer Surveillance System (CSS). Matched comparison cases from CSS will be identified by CSS and confirmed by the FHCRC investigator."
                        }
                    ]
                }
            },
            "OutcomesModule": {
                "PrimaryOutcomeList": {
                    "PrimaryOutcome": [
                        {
                            "PrimaryOutcomeMeasure": "Aim 1: Describe treatments received by breast cancer patients receiving physician level practitioner IO care and the cost of IO care.",
                            "PrimaryOutcomeDescription": "Will also describe how long after diagnosis women with breast cancer seek IO care and differences in IO care prescriptions associated with when, in a woman's course of treatment, she seeks care. This patient cohort will consist of all female patients with breast cancer seeking IO clinic care. Our analyses will describe how long after diagnosis women with breast cancer seek IO care and describe differences in IO care prescriptions associated with when, in a woman's course of treatment, she seeks care.",
                            "PrimaryOutcomeTimeFrame": "Baseline, 6, 12, 24, 36, 48, and 60 months post study enrollment."
                        },
                        {
                            "PrimaryOutcomeMeasure": "Aim 2: Compare health-related quality of life (HRQOL) experienced by a group of breast cancer patients receiving IO care with HRQOL of a group of matched comparison women.",
                            "PrimaryOutcomeDescription": "Comparison will be between breast cancer patients living in the same geographic area with similar prognostic characteristics (age, stage of cancer at diagnosis, estrogen receptor/ progesterone receptor (ER/PR) status, race, ethnicity, and marital status) at the time of their initial diagnosis with breast cancer who did not receive IO care. We will identify an average of three (up to four each) matched controls for each eligible IO clinic cancer patient from the Western Washington CSS database and to invite them to enroll in the outcomes study.",
                            "PrimaryOutcomeTimeFrame": "6-60 months post-enrollment"
                        }
                    ]
                },
                "SecondaryOutcomeList": {
                    "SecondaryOutcome": [
                        {
                            "SecondaryOutcomeMeasure": "Aim 3: Collect pilot data on survival, comorbidities, and abnormal laboratory values.",
                            "SecondaryOutcomeDescription": "Collect pilot data on disease-free, progression free, and overall survival, as well as comorbidities and abnormal laboratory values at 6 months post-enrollment for all Cohort 1 and Cohort 2. We will collect data at 1 year post-enrollment and then yearly on disease-free, progression free, and overall survival, as well as comorbidities for as long as funding is available in a nested cohort of IO breast cancer patients (Cohort 1A) and their matched comparison group who did not receive care at any of the IO clinical sites (Cohort 2).",
                            "SecondaryOutcomeTimeFrame": "6-60 months post-enrollment"
                        },
                        {
                            "SecondaryOutcomeMeasure": "Aim 4: Describe and compare CAM treatments",
                            "SecondaryOutcomeDescription": "Describe and compare the frequency of use of a variety of CAM treatments used by breast cancer patients who do (Cohort 1A) and do not (Cohorts 2A and 2B) receive IO care from an IO specialist.",
                            "SecondaryOutcomeTimeFrame": "Baseline, 6, 12, 24, 48, and 60 months"
                        },
                        {
                            "SecondaryOutcomeMeasure": "Aim 5: Compare the HRQOL of women who self-prescribe CAM with those who do not",
                            "SecondaryOutcomeDescription": "To compare baseline and changes in HRQOL in breast cancer patients who self-prescribe CAM (Cohort 2B) matched with comparison women who do not use CAM (Cohort 2A).",
                            "SecondaryOutcomeTimeFrame": "Baseline and 6, 12, 24, 36, 48 and 60 months post-enrollment"
                        }
                    ]
                }
            },
            "EligibilityModule": {
                "EligibilityCriteria": "The patients enrolled into the study will include patients who meet the following criteria:\n\nCohort 1: IO clinic breast cancer patients\n\nConfirmed breast cancer of primary breast cancer with ICD9 code of 174.x, 233.0 or V10.3\nFemale\n\u226518 years of age\nCan provide signed informed consent\n1st IO clinic visit \u22643 months prior to enrollment\nCan read and understand the questionnaires\n\nCohort 1A: Sub-cohort of IO clinic patients (cases) who meet the following additional criteria and for whom matched controls have been found from the CSS database.\n\nICD9 code of 174.x or 233.0\nPrimary ductal or lobular breast cancer diagnosis \u22642 years prior to 1st IO clinic visit\nMinimum of two IO clinic visits within 7 months\nProvided Baseline Questionnaire\n\nCohort 2: Matched controls from CSS database for Cohort 1A patients\n\nConfirmed breast cancer\nFemale\n\u2265 18 years of age\nCan provide informed consent",
                "HealthyVolunteers": "No",
                "Gender": "Female",
                "MinimumAge": "18 Years",
                "StdAgeList": {
                    "StdAge": [
                        "Adult",
                        "Older Adult"
                    ]
                },
                "StudyPopulation": "Eligible participants for the study will include patients who are receiving care for their cancer at participating Seattle area IO clinics. An average of two (up to four) matched comparison controls will be recruited from the Washington State CSS.\n\nAll breast cancer patients seeking care at the participating IO clinics who meet inclusion/exclusion criteria are eligible to participate in this study. Matched comparison cases from CSS will be identified by CSS and confirmed by the FHCRC investigator.",
                "SamplingMethod": "Non-Probability Sample"
            },
            "ContactsLocationsModule": {
                "OverallOfficialList": {
                    "OverallOfficial": [
                        {
                            "OverallOfficialName": "Leanna J. Standish, ND, PhD, FABNO",
                            "OverallOfficialAffiliation": "Bastyr University",
                            "OverallOfficialRole": "Principal Investigator"
                        },
                        {
                            "OverallOfficialName": "M. Robyn Andersen, PhD, MPH",
                            "OverallOfficialAffiliation": "Fred Hutchinson Cancer Center",
                            "OverallOfficialRole": "Principal Investigator"
                        }
                    ]
                },
                "LocationList": {
                    "Location": [
                        {
                            "LocationFacility": "Red Cedar Wellness Center",
                            "LocationCity": "Bellevue",
                            "LocationState": "Washington",
                            "LocationZip": "98004",
                            "LocationCountry": "United States"
                        },
                        {
                            "LocationFacility": "Bastyr Integrative Oncology Research Center",
                            "LocationCity": "Kenmore",
                            "LocationState": "Washington",
                            "LocationZip": "98028",
                            "LocationCountry": "United States"
                        },
                        {
                            "LocationFacility": "Seattle Integrative Oncology at Providence Integrative Cancer Care",
                            "LocationCity": "Lacey",
                            "LocationState": "Washington",
                            "LocationZip": "98503",
                            "LocationCountry": "United States"
                        },
                        {
                            "LocationFacility": "Seattle Cancer Treatment & Wellness Center",
                            "LocationCity": "Renton",
                            "LocationState": "Washington",
                            "LocationZip": "98057",
                            "LocationCountry": "United States"
                        },
                        {
                            "LocationFacility": "Seattle Integrative Oncology at Institute of Complementary Medicine",
                            "LocationCity": "Seattle",
                            "LocationState": "Washington",
                            "LocationZip": "98122",
                            "LocationCountry": "United States"
                        },
                        {
                            "LocationFacility": "Tree of Health Integrative Medicine",
                            "LocationCity": "Woodinville",
                            "LocationState": "Washington",
                            "LocationZip": "98072",
                            "LocationCountry": "United States"
                        }
                    ]
                }
            },
            "ReferencesModule": {
                "ReferenceList": {
                    "Reference": [
                        {
                            "ReferencePMID": "29701107",
                            "ReferenceType": "derived",
                            "ReferenceCitation": "Standish LJ, Dowd F, Sweet E, Dale L, Andersen MR. Do Women With Breast Cancer Who Choose Adjunctive Integrative Oncology Care Receive Different Standard Oncologic Treatment? Integr Cancer Ther. 2018 Sep;17(3):874-884. doi: 10.1177/1534735418769007. Epub 2018 Apr 27."
                        }
                    ]
                }
            }
        },
        "DerivedSection": {
            "MiscInfoModule": {
                "VersionHolder": "September 08, 2023"
            },
            "ConditionBrowseModule": {
                "ConditionMeshList": {
                    "ConditionMesh": [
                        {
                            "ConditionMeshId": "D000001943",
                            "ConditionMeshTerm": "Breast Neoplasms"
                        }
                    ]
                },
                "ConditionAncestorList": {
                    "ConditionAncestor": [
                        {
                            "ConditionAncestorId": "D000009371",
                            "ConditionAncestorTerm": "Neoplasms by Site"
                        },
                        {
                            "ConditionAncestorId": "D000009369",
                            "ConditionAncestorTerm": "Neoplasms"
                        },
                        {
                            "ConditionAncestorId": "D000001941",
                            "ConditionAncestorTerm": "Breast Diseases"
                        },
                        {
                            "ConditionAncestorId": "D000012871",
                            "ConditionAncestorTerm": "Skin Diseases"
                        }
                    ]
                },
                "ConditionBrowseLeafList": {
                    "ConditionBrowseLeaf": [
                        {
                            "ConditionBrowseLeafId": "M4910",
                            "ConditionBrowseLeafName": "Breast Neoplasms",
                            "ConditionBrowseLeafAsFound": "Breast Cancer",
                            "ConditionBrowseLeafRelevance": "high"
                        },
                        {
                            "ConditionBrowseLeafId": "M4908",
                            "ConditionBrowseLeafName": "Breast Diseases",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M15364",
                            "ConditionBrowseLeafName": "Skin Diseases",
                            "ConditionBrowseLeafRelevance": "low"
                        }
                    ]
                },
                "ConditionBrowseBranchList": {
                    "ConditionBrowseBranch": [
                        {
                            "ConditionBrowseBranchAbbrev": "BC04",
                            "ConditionBrowseBranchName": "Neoplasms"
                        },
                        {
                            "ConditionBrowseBranchAbbrev": "BC17",
                            "ConditionBrowseBranchName": "Skin and Connective Tissue Diseases"
                        },
                        {
                            "ConditionBrowseBranchAbbrev": "All",
                            "ConditionBrowseBranchName": "All Conditions"
                        }
                    ]
                }
            }
        }
    }
}